...
首页> 外文期刊>Transplantation: Official Journal of the Transplantation Society >Graft function 5-7 years after renal transplantation in early childhood.
【24h】

Graft function 5-7 years after renal transplantation in early childhood.

机译:儿童早期肾移植后5-7年的移植功能。

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

BACKGROUND: Low recipient age is still a risk factor for graft failure after kidney transplantation (Tx). Detailed prospective reports on long-term graft function in small children after renal Tx are still lacking. METHODS: Forty-nine kidney allograft recipients who received transplants before the age of 5 years were followed prospectively. The most common disease was congenital nephrotic syndrome of the Finnish type. Twenty patients were recipients of living related donors (LRD), and 29 were cadaveric kidney (CAD) recipients. All patients received triple immunosuppression. Glomerular filtration rate (GFR), effective renal plasma flow (ERPF), sodium, urate, and potassium handling, and concentrating capacity were studied for up to 7 years after Tx. RESULTS: Patient survival 7 years after Tx was 100% for LRD and 96% for CAD recipients. Graft survival was 94% for LRD and 79% for CAD recipients (P=NS) and 89% and 83% for children >2 years and <2 years of age at Tx, respectively (P=NS). Five years after Tx, GFR was 70 vs. 64 and ERPF was 380 vs. 310 ml/min/1.73 m2 for LRD and CAD recipients, respectively (P=NS). Mean absolute GFR remained stable. GFR was lower in children who received transplants at <2 years than in children who received transplants at >2 years of age, 54 vs. 75 ml/min/1.73 m2 (P=0.02). Sodium handling remained intact, but hyperuricemia was seen in 43-67%; 17-33% showed abnormal handling of potassium; and most patients had a subnormal concentrating capacity. CONCLUSIONS: Excellent long-term graft survival and good graft function can be achieved with triple immunosuppression, even in young CAD kidney recipients.
机译:背景:低接受者年龄仍然是肾移植(Tx)后移植失败的危险因素。仍缺乏关于小儿肾移植术后长期移植物功能的详细前瞻性报告。方法:前瞻性地追踪了在5岁之前接受移植的49位肾脏同种异体移植受者。最常见的疾病是芬兰型先天性肾病综合征。 20名患者是与生活相关的捐献者(LRD)的接受者,而29名是尸体肾脏(CAD)接受者。所有患者均接受了三重免疫抑制。在Tx后长达7年的研究中,研究了肾小球滤过率(GFR),有效肾血浆流量(ERPF),钠,尿酸盐和钾的处理以及浓缩能力。结果:Tx后7年的患者生存率,LRD为100%,CAD接受者为96%。 Lx的LRD移植存活率为94%,CAD的移植存活率为79%(P = NS),Tx年龄大于2岁和小于2岁的儿童的移植存活率分别为89%和83%(P = NS)。 Tx五年后,LRD和CAD接受者的GFR分别为70 vs. 64和ERPF分别为380 vs. 310 ml / min / 1.73 m2(P = NS)。平均绝对GFR保持稳定。 <2岁接受移植的儿童的GFR低于> 2岁接受移植的儿童的GFR,分别为54和75 ml / min / 1.73 m2(P = 0.02)。钠处理完好无损,但高尿酸血症的发生率为43-67%; 17-33%的人发现钾处理异常;而且大多数患者的注意力集中能力都低于正常水平。结论:即使在年轻的CAD肾脏接受者中,也可以通过三重免疫抑制获得出色的长期移植物存活率和良好的移植物功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号